Using the dMyc-lacZ reporter, we found that dMyc transcriptional activation remained robust when pfk2 or pfk was depleted in Hipk tumor cells even though the tumor growth was reduced and dMyc protein levels were reduced (Figure 6e–g). The gene discussed is PFKFB3; the disease is neoplasm.